Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Indian J Med Sci ; 2010 June; 64(6) 245-252
Article Dans Anglais | IMSEAR | ID: sea-145536

Résumé

Objectives: To identify the adverse drug reactions (ADRs) to antiretroviral therapy (ART) and to assess their impact on treatment compliance in patients with HIV/AIDS. Materials and Methods: Two hundred and thirty-five (235) AIDS patients who received ART were monitored for ADRs over a period of 6 months. The incidence and nature of ADRs occurring with different ART regimens were recorded. We also assessed the severity, causality as well as the impact of ADRs on the patients' compliance. Results: Of 235 patients receiving ART, 90.6% patients experienced ADRs. A total of 618 ADRs involving various systems were observed. A majority were related to gastrointestinal (42.39%) and central nervous (25.57%) system. 23.1% ADRs were severe in intensity. Severe ADRs occurred in 41 out of 235 (17.4%) patients necessitating drug withdrawal. A majority of the patients (87.8%) who complained of severe ADRs received combination of stavudine, lamivudine and nevirapine. Causality assessment revealed 6.63% ADRs were probable and 93.3% ADRs were possible. Non-compliance due to ADRs was observed in 28.9% patients. Conclusions: Myriad ADRs are associated with ART which leads to poor patient compliance. With the increasing access to ART in India, it is prudent that antiretroviral drugs are used judicially with regular monitoring of ADRs.


Sujets)
Adolescent , Adulte , Sujet âgé , Syndrome d'immunodéficience acquise/traitement médicamenteux , Thérapie antirétrovirale hautement active , Association médicamenteuse/effets indésirables , Femelle , VIH (Virus de l'Immunodéficience Humaine)/effets des médicaments et des substances chimiques , Hôpitaux , Humains , Inde , Lamivudine/effets indésirables , Mâle , Adulte d'âge moyen , Névirapine/effets indésirables , Observance par le patient/effets des médicaments et des substances chimiques , Pharmacovigilance , Stavudine/effets indésirables , Centres de soins tertiaires , Jeune adulte
SÉLECTION CITATIONS
Détails de la recherche